TYROSINE KINASE INHIBITORS MANAGEMENT AFTER ALLOGENEIC STEM CELL TRANSPLANTATION FOR PH+ ALL: LESSONS FROM A PEDIATRIC CHALLENGING CASE
AH Melgaçoa, RCBS Tavaresa, LBA Limab, MT Schrammb, PRCB Horna, SC Maradeia, BE Gomesc, LM Gutiyamac, D Lernera, TS Fernandezc
a Centro de Transplante de Medula Óssea (CEMO), Instituto Nacional de Câncer (INCA), Rio de Janeiro, RJ, Brazil
b Departamento de Hematologia, Instituto Nacional de Câncer (INCA), Rio de Janeiro, RJ, Brazil
c Divisão de Laboratório, Centro de Transplante de Medula Óssea (CEMO), Instituto Nacional de Câncer (INCA), Rio de Janeiro, RJ, Brazil
Read
1172
Timeswas read the article
494
Total PDF
678
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 7 | 26 | 24 | 50 |
| 2025 6 | 33 | 15 | 48 |
| 2025 5 | 46 | 14 | 60 |
| 2025 4 | 37 | 13 | 50 |
| 2025 3 | 42 | 15 | 57 |
| 2025 2 | 38 | 23 | 61 |
| 2025 1 | 25 | 20 | 45 |
| 2024 12 | 21 | 10 | 31 |
| 2024 11 | 30 | 18 | 48 |
| 2024 10 | 32 | 19 | 51 |
| 2024 9 | 49 | 25 | 74 |
| 2024 8 | 38 | 22 | 60 |
| 2024 7 | 33 | 25 | 58 |
| 2024 6 | 37 | 22 | 59 |
| 2024 5 | 32 | 15 | 47 |
| 2024 4 | 33 | 22 | 55 |
| 2024 3 | 11 | 9 | 20 |
| 2024 2 | 10 | 15 | 25 |
| 2024 1 | 7 | 7 | 14 |
| 2023 12 | 8 | 17 | 25 |
| 2023 11 | 11 | 14 | 25 |
| 2023 10 | 8 | 23 | 31 |
| 2023 9 | 10 | 17 | 27 |
| 2023 8 | 6 | 17 | 23 |
| 2023 7 | 8 | 1 | 9 |
| 2023 6 | 8 | 12 | 20 |
| 2023 5 | 8 | 6 | 14 |
| 2023 4 | 4 | 5 | 9 |
| 2023 3 | 3 | 7 | 10 |
| 2023 2 | 5 | 10 | 15 |
| 2023 1 | 5 | 5 | 10 |
| 2022 12 | 8 | 15 | 23 |
| 2022 11 | 4 | 7 | 11 |
| 2022 10 | 2 | 5 | 7 |
Show all
